Physician profile
Timothy S Ackerman
NPI 1609879535
$2,354.90
in general payments reported to CMS, 2019-2025
11 companies · $50.49 in 2025
The $50.49 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.27 · 2020: $24.81 · 2021: $129 · 2022: $1,353 · 2023: $281 · 2024: $427 · 2025: $50.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Gift: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.99 |
| Gift | $262.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Solutions LLC | $1,373.79 | 2019-2022 | |
| Smith+Nephew, INC. | $421.59 | 2021-2024 | Visionaire, Real Intelligence, Polarstem |
| Arthrex, INC. | $153.84 | 2023 | |
| Novus Surgical Consultants | $100.04 | 2023-2024 | |
| Medtronic, INC. | $95.74 | 2021 | |
| Microport Orthopedics INC | $54.87 | 2023 | Mpo Hip System |
| Linvatec Corporation | $50.49 | 2025 | |
| Ermi LLC | $36.76 | 2020-2021 | |
| Stryker Corporation | $36.48 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.61 | 2022 | |
| Merck Sharp & Dohme LLC | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.